Banque Cantonale Vaudoise’s Madrigal Pharmaceuticals MDGL Stock Holding History

Banque Cantonale Vaudoise’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$451K	Buy	+862	New	+$412K	0.02%	511
2022 Q1	–	Sell	-1,500	Closed	-$127K	–	1356
2021 Q4	$127K	Hold	1,500	–	–	0.01%	919
2021 Q3	$120K	Hold	1,500	–	–	0.01%	908
2021 Q2	$146K	Hold	1,500	–	–	0.01%	896
2021 Q1	$175K	Hold	1,500	–	–	0.01%	802
2020 Q4	$167K	Hold	1,500	–	–	0.01%	762
2020 Q3	$178K	Buy	+1,500	New	+$163K	0.01%	715

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Banque Cantonale Vaudoise's MDGL Position: Q1 2026 in Review

Banque Cantonale Vaudoise opened a new position in Madrigal Pharmaceuticals (MDGL) in Q1 2026: 862 shares worth $451K. The stake represents 0.02% of the portfolio and ranks #511 among its holdings. This is a return to the name: Banque Cantonale Vaudoise previously reported a position in MDGL as recently as Q4 2021.

Banque Cantonale Vaudoise first reported a position in MDGL in Q3 2020 and has held it in 7 quarters since. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

Banque Cantonale Vaudoise held 862 shares of Madrigal Pharmaceuticals worth $451K as of Q1 2026.
Madrigal Pharmaceuticals was a new Banque Cantonale Vaudoise position in Q1 2026.
Madrigal Pharmaceuticals made up 0.02% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #511 holding.
Banque Cantonale Vaudoise first reported a position in Madrigal Pharmaceuticals in Q3 2020 and has held it in 7 quarters since.
378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.